Document is current
Any future updates will be listed below
-
Authors
Linse, Sara https://orcid.org/0000-0001-9629-7109
Scheidt, Tom https://orcid.org/0000-0002-0185-7730
Bernfur, Katja
Vendruscolo, Michele https://orcid.org/0000-0002-3616-1610
Dobson, Christopher M. https://orcid.org/0000-0002-5445-680X
Cohen, Samuel I. A.
Sileikis, Eimantas https://orcid.org/0000-0002-2849-5186
Lundqvist, Martin
Qian, Fang
O’Malley, Tiernan https://orcid.org/0000-0002-3538-0731
Bussiere, Thierry https://orcid.org/0000-0002-6818-4876
Weinreb, Paul H. https://orcid.org/0000-0002-0802-0052
Xu, Catherine K.
Meisl, Georg https://orcid.org/0000-0002-6562-7715
Devenish, Sean R. A.
Knowles, Tuomas P. J. https://orcid.org/0000-0002-7879-0140
Hansson, Oskar https://orcid.org/0000-0001-8467-7286
- License Information
-
More Information
Article History
Received: 2 March 2020
Accepted: 13 August 2020
First Online: 28 September 2020
Competing interests
: S.L. acquired research support (for the institution) from Biogen to cover the costs for the kinetic experiments and analyses as well as the oligomer generation experiments and analyses. O.H. has acquired research support (for the institution) from Roche, GE Healthcare, Biogen, AVID Radiopharmaceuticals and Euroimmun. In the past 2 years, he has received consultancy/speaker fees from Biogen and Roche. S.L., S.I.A.C., M.V., C.M.D. and T.P.J.K. are founders and shareholders of Wren Therapeutics Ltd, where S.L., S.I.A.C., M.V., E.S. and T.P.J.K. are also employees. P.H.W., F.Q. and T.B. are employees and shareholders of Biogen. T.P.J.K. is a founder and S.R.A.D. is an employee of Fluidic Analytics.
